WallStSmart
CELZ

Creative Medical Technology Holdings Inc

NASDAQ: CELZ · HEALTHCARE · BIOTECHNOLOGY

$2.25
+1.35% today

Updated 2026-04-30

Market cap
$8.50M
P/E ratio
P/S ratio
1,417.06x
EPS (TTM)
$-2.52
Dividend yield
52W range
$2 – $6
Volume
0.1M

WallStSmart proprietary scores

30
out of 100
Grade: F
Strong Sell
Investment rating
5.3
Growth
C+
5.0
Quality
C+
2.5
Profitability
F
5.0
Valuation
C+
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target
$20.00
+788.89%
12-Month target
Intrinsic (DCF)
Margin of safety

Price chart

X-Ray snapshot

Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-1.94M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$88600.00$9000.00$11000.00$6000.00$6000.00
Net income$-10.14M$-5.29M$-5.49M$-6.00M$-1.89M
EPS$-2.52
Free cash flow$-7.80M$-8.13M$-5.50M$-5.86M$-1.94M
Profit margin-11,449.26%-58,739.71%-49,940.74%-99,916.80%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
CELZ$8.50M305.32.55.05.0Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$322.34B545.35.57.34.8+42.06%Buy
AZN$294.17B646.78.05.35.0+4.07%Buy

Smart narrative

Creative Medical Technology Holdings Inc trades at $2.25. Our Smart Value Score of 30/100 indicates the stock is weak. TTM revenue stands at $6000.00.

Frequently asked questions

What is Creative Medical Technology Holdings Inc's stock price?
Creative Medical Technology Holdings Inc (CELZ) trades at $2.25.
Is Creative Medical Technology Holdings Inc overvalued?
Smart Value Score 30/100 (Grade F, Strong Sell).
What is the price target of Creative Medical Technology Holdings Inc (CELZ)?
The analyst target price is $20.00, representing +788.9% upside from the current price of $2.25.
What is Creative Medical Technology Holdings Inc's revenue?
TTM revenue is $6000.00.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio1,417.06x
ROE-86.50%
Beta1.99
50D MA$1.99
200D MA$2.64
Shares out0.00B
Float0.00B
Short ratio
Avg volume0.1M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years